tiprankstipranks
Trending News
More News >
Innate Pharma SA (FR:IPH)
:IPH

Compare Innate Pharma SA (IPH) vs. Competitors

Compare
10 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma SA
€1.62
€145.08M
-2.82
-11.34%
Genfit
$6.64
$331.46M
-7.85
68.61%
1 Buy
0 Hold
0 Sell
Moderate Buy
DBV Technologies
€3.80
€763.63M
-4.00
367.94%
1 Buy
0 Hold
0 Sell
Moderate Buy
Nanobiotix
€18.22
€844.82M
418.43%
1 Buy
0 Hold
0 Sell
Moderate Buy
OSE Immunotherapeutics SA
€5.12
€106.59M
-3.02
-26.52%
Sensorion SAS
€0.43
€180.21M
-4.58
-26.46%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
FR:IPH
Innate Pharma SA
1.55
-0.25
-14.00%
GNFTF
Genfit
6.64
2.88
76.46%
GB:0QAJ
DBV Technologies
3.80
2.99
372.01%
GB:0QAV
Nanobiotix
17.98
14.47
412.22%
DE:6OP
OSE Immunotherapeutics SA
4.78
-1.82
-27.64%
DE:RFM
Sensorion SAS
0.43
-0.16
-27.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts